CTKB Stock Analysis: Buy, Sell, or Hold?
CTKB - Cytek Biosciences, Inc. Common Stock
$5.13
0.13 (2.60%)
▲
5d:
-1.35%
30d:
+1.58%
90d:
+34.29%
BUY
HIGH Confidence
Last Updated: February 2, 2026
Earnings: Feb 26, 2026
23d
Get Alerted When CTKB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CTKB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: CTKB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: CTKB is currently trading at $5.13, which is considered slightly low relative to its 30-day fair value range of $5.06 to $5.55.
Technical Outlook: Technically, CTKB is in a strong uptrend. Immediate support is located at $4.86, while resistance sits at $5.70.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.00 (+20.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CTKB is in a strong uptrend. Immediate support is located at $4.86, while resistance sits at $5.70.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.00 (+20.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$5.06 -
$5.55
Company Quality Score
47/100
(HOLD)
Options IV Signal
47th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
77.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 47th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($6.00)
Fair Price Analysis
30-Day Fair Range
$5.06 -
$5.55
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$0.65
(12.7%)
Support & Resistance Levels
Support Level
$4.86
Resistance Level
$5.70
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-333.33
Wall Street Target
$6.00
(+20.0%)
Revenue Growth (YoY)
1.5%
Earnings Growth (YoY)
73.5%
Profit Margin
-6.5%
Last updated: February 02, 2026 3:17 PM ET
Data refreshes hourly during market hours. Next update: 4:17 PM
Data refreshes hourly during market hours. Next update: 4:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTKB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 66 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 57 HOLD |
